Get a glimpse into our company and investor data—powered by the PitchBook Platform
Sirion Therapeutics (Zirgan)
Asset Purch.LATEST DEAL TYPE
Assets and U.S. rights for Zirgan. It is a topical anti-viral for the treatment of corneal ulcers. It conveys special status for rare diseases or conditions that affect fewer than 200,000 patients in the U.S.